Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chemotherapy plus enzalutamide in first-line therapy for castration-resistant prostate cancer
2014-000175-43Phase 2Active
- Sponsor
- Azienda Provinciale per i Servizi Sanitari
- Start
- Jun 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of enzalutamide in prostate cancer (PCa) (2 arms), sponsored by Azienda Provinciale per i Servizi Sanitari. Started Jun 2014; status: active.
02
Drugs
enzalutamide
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on 2014-000175-43.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-000175-43.